Anatolian Journal of Cardiology最新文献

筛选
英文 中文
Environmental Factors for Cardiovascular Disease, PAPCAT study and more…. 心血管疾病的环境因素,PAPCAT研究等....
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-10-01 DOI: 10.14744/AnatolJCardiol.2025.10
Çetin Erol
{"title":"Environmental Factors for Cardiovascular Disease, PAPCAT study and more….","authors":"Çetin Erol","doi":"10.14744/AnatolJCardiol.2025.10","DOIUrl":"10.14744/AnatolJCardiol.2025.10","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":"29 10","pages":"524"},"PeriodicalIF":1.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145190702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Hidden Burden of Premature Cardiovascular Disease in a National Leader: Mustafa Kemal Atatürk's Familial Risk, Lifestyle, and Occupational Stress. 国家领导人早发心血管疾病的隐性负担:穆斯塔法·凯末尔的家族风险、生活方式和职业压力。
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-22 DOI: 10.14744/AnatolJCardiol.2025.5729
Meral Kayıkçıoğlu
{"title":"The Hidden Burden of Premature Cardiovascular Disease in a National Leader: Mustafa Kemal Atatürk's Familial Risk, Lifestyle, and Occupational Stress.","authors":"Meral Kayıkçıoğlu","doi":"10.14744/AnatolJCardiol.2025.5729","DOIUrl":"10.14744/AnatolJCardiol.2025.5729","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145111756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Mimicker of Hypertrophic Cardiomyopathy: Infiltrative Cardiac Lipoma. 一种罕见的肥厚性心肌病模仿者:浸润性心脏脂肪瘤。
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-22 DOI: 10.14744/AnatolJCardiol.2025.5630
Muhammet Tekin, Duygu İnan, Aslan Erdoğan, Ayşe İrem Demirtola Mammadli, Yiğit Can Kartal, Nihan Kayalar, Alev Kılıçgedik
{"title":"A Rare Mimicker of Hypertrophic Cardiomyopathy: Infiltrative Cardiac Lipoma.","authors":"Muhammet Tekin, Duygu İnan, Aslan Erdoğan, Ayşe İrem Demirtola Mammadli, Yiğit Can Kartal, Nihan Kayalar, Alev Kılıçgedik","doi":"10.14744/AnatolJCardiol.2025.5630","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5630","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145111803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Letter to the Editor: "Is a Single Nitroglycerin Study Sufficient to Say that It Is Safe Not to Give Nitroglycerin Before Radial Intervention?" 回复致编辑的信:“一项硝酸甘油研究是否足以说明在放射干预前不给予硝酸甘油是安全的?”
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-22 DOI: 10.14744/AnatolJCardiol.2025.5529
Mehmet Karaca, Bahadır Dağdeviren
{"title":"Reply to Letter to the Editor: \"Is a Single Nitroglycerin Study Sufficient to Say that It Is Safe Not to Give Nitroglycerin Before Radial Intervention?\"","authors":"Mehmet Karaca, Bahadır Dağdeviren","doi":"10.14744/AnatolJCardiol.2025.5529","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5529","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145111753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Letter to the Editor: "The Increase in Pediatric Postural Orthostatic Tachycardia Syndrome During the Pandemic May be due to Autonomic Neuropathy as a Complication of SARS-CoV-2 Infection". 回复编辑:“大流行期间儿童体位性心动过速综合征的增加可能是由于自主神经病变作为SARS-CoV-2感染的并发症”。
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-22 DOI: 10.14744/AnatolJCardiol.2025.5764
Mustafa Mertkan Bilen, Gamze Vuran, Murat Muhtar Yılmazer, Timur Meşe, Cem Doğan
{"title":"Reply to Letter to the Editor: \"The Increase in Pediatric Postural Orthostatic Tachycardia Syndrome During the Pandemic May be due to Autonomic Neuropathy as a Complication of SARS-CoV-2 Infection\".","authors":"Mustafa Mertkan Bilen, Gamze Vuran, Murat Muhtar Yılmazer, Timur Meşe, Cem Doğan","doi":"10.14744/AnatolJCardiol.2025.5764","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5764","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145111829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Cardiac Rehabilitation Exercise Plus Sacubitril Valsartan Sodium on Cardiac Function, Lung Function, and Quality of Life in Patients with Chronic Heart Failure. 心脏康复运动加沙比利缬沙坦钠对慢性心力衰竭患者心功能、肺功能和生活质量的影响
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-19 DOI: 10.14744/AnatolJCardiol.2025.5434
Xiaoqi Li, Ping Zhang, Jinlun Cai, Liu Shi, Qiaoyan Ma, Zhongwen Xue
{"title":"Effects of Cardiac Rehabilitation Exercise Plus Sacubitril Valsartan Sodium on Cardiac Function, Lung Function, and Quality of Life in Patients with Chronic Heart Failure.","authors":"Xiaoqi Li, Ping Zhang, Jinlun Cai, Liu Shi, Qiaoyan Ma, Zhongwen Xue","doi":"10.14744/AnatolJCardiol.2025.5434","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5434","url":null,"abstract":"<p><strong>Background: </strong>To explore the impacts of cardiac rehabilitation exercise plus sacubitril valsartan sodium on cardiac function, lung function, and quality of life in chronic heart failure (CHF) patients.</p><p><strong>Methods: </strong>One hundred and forty-six CHF patients admitted to the hospital from January 2023 to December 2024 were chosen and divided into a control group (conventional treatment + sacubitril valsartan sodium) and a study group (conventional treatment + sacubitril valsartan sodium + cardiac rehabilitation exercise).</p><p><strong>Results: </strong>The total effective rate of the study group was higher when comparing with the control group (P < .05). The study group had higher left ventricular ejection fraction level as well as lower left ventricular end-systolic diameter, left ventricular end-diastolic diameter, and N-terminal pro B-type natriuretic peptide levels when comparing with the control group after 3 months of intervention (P < .01). The study group had higher forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC levels when comparing with the control group following 3 months of intervention (P < .01). The study group had higher SpO2, PaO2, and PaO2/FiO2 levels after 3 months of intervention (P < .01). The study group had longer 6-minute walking test after 3 months of intervention (P < .01). The study group had lower MLHFQ score when comparing with the control group after 3 months of intervention (P < .01). The rate of rehospitalization and incidence of major adverse cardiovascular event (MACE) in the study group were lower than in the control group (P < .05).</p><p><strong>Conclusion: </strong>Cardiac rehabilitation exercise combined with sacubitril valsartan sodium is effective in treating CHF patients, which improves cardiac function, lung function and blood gas levels, promotes exercise endurance and quality of life, and reduces the rehospitalization rate and MACE incidence in CHF patients.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145090979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Electrocardiographic Index to Predict the Severity of Coronary Calcification. 一种预测冠状动脉钙化严重程度的新型心电图指标。
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-19 DOI: 10.14744/AnatolJCardiol.2025.5437
Serkan Duyuler, Koray Arslan, Raif Can Karabulut, Atik Aksoy, Mustafa Dağlı, Pınar Türker Duyuler
{"title":"A Novel Electrocardiographic Index to Predict the Severity of Coronary Calcification.","authors":"Serkan Duyuler, Koray Arslan, Raif Can Karabulut, Atik Aksoy, Mustafa Dağlı, Pınar Türker Duyuler","doi":"10.14744/AnatolJCardiol.2025.5437","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5437","url":null,"abstract":"<p><strong>Objective: </strong>Electrocardiogram (ECG) remains an essential tool in cardiology. Coronary artery calcium (CAC) score, measured via computed tomography, is a well-established predictor of cardiovascular risk. However, its cost and availability limit widespread use. This study introduces a novel ECG-based index, the PARLA (Prediction of Ischemia via Angle of QRS-T and corrected QT Length Assessment) Index, combining the QTc interval and frontal QRS-T (fQRS-T) angle, to assess its association with CAC severity.</p><p><strong>Methods: </strong>This retrospective, cross-sectional study included patients who underwent ECG and coronary computed tomography angiography. Exclusion criteria encompassed conduction abnormalities, significant valvular disease, cardiomyopathy, prior coronary interventions, and medications affecting ECG parameters. The PARLA Index was defined as the sum of the QTc interval and absolute fQRS-T angle. Patients were classified based on CAC score: <100 (low CAC score) vs. ≥100 (high CAC score). Statistical analyses, including logistic regression and receiver operating characteristic (ROC) curve analysis, assessed the predictive value of the PARLA Index for CAC severity.</p><p><strong>Results: </strong>Among 595 patients (mean age 53.4 ± 11.6 years, 39.5% female), the high-CAC group had older age, higher prevalence of hypertension and diabetes, and greater left ventricular wall thickness. The PARLA Index was significantly higher in the high-CAC group (440± 26 vs. 465 ± 37, P < .001). Multivariate regression identified the PARLA Index as an independent predictor of CAC ≥100 (OR: 1.021, P < .001). ROC analysis determined an optimal PARLA Index cut-off of 450 (AUC: 0.705, sensitivity: 63%, specificity: 66%).</p><p><strong>Conclusions: </strong>The PARLA Index is a novel, simple ECG-derived parameter that correlates with CAC severity and may serve as a noninvasive tool for cardiovascular risk stratification. Future studies should validate its prognostic value.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145090933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is a Single Nitroglycerin Study Sufficient to Say That It Is Safe Not to Give Nitroglycerin Before Radial Intervention? 一项单独的硝酸甘油研究是否足以说明在放射干预前不给予硝酸甘油是安全的?
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-18 DOI: 10.14744/AnatolJCardiol.2025.5528
Sefa Erdi Ömür, Çağrı Zorlu
{"title":"Is a Single Nitroglycerin Study Sufficient to Say That It Is Safe Not to Give Nitroglycerin Before Radial Intervention?","authors":"Sefa Erdi Ömür, Çağrı Zorlu","doi":"10.14744/AnatolJCardiol.2025.5528","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5528","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and Safety of Reduced-Dose and Slow-Infusion Intravenous Tissue-Type Plasminogen Activator Regimen in Patients with Acute Pulmonary Embolism at Intermediate-High Risk. 低剂量慢速静脉输注组织型纤溶酶原激活剂治疗急性肺栓塞中高危患者的有效性和安全性
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-18 DOI: 10.14744/AnatolJCardiol.2025.5524
Barkın Kültürsay, Seda Tanyeri, Berhan Keskin, Hacer Ceren Tokgöz, Dicle Sırma, Çağdaş Buluş, Şeyma Zeynep Atıcı, Şeyma Nur Çiçek, Furkan Baturalp Erdoğan, Ahmet Sekban, Mustafa Bulut, Zübeyde Bayram, Selahattin Akyol, Aykun Hakgör, Şeyhmus Külahçıoğlu, Ali Karagöz, Nihal Özdemir, Cihangir Kaymaz
{"title":"Effectiveness and Safety of Reduced-Dose and Slow-Infusion Intravenous Tissue-Type Plasminogen Activator Regimen in Patients with Acute Pulmonary Embolism at Intermediate-High Risk.","authors":"Barkın Kültürsay, Seda Tanyeri, Berhan Keskin, Hacer Ceren Tokgöz, Dicle Sırma, Çağdaş Buluş, Şeyma Zeynep Atıcı, Şeyma Nur Çiçek, Furkan Baturalp Erdoğan, Ahmet Sekban, Mustafa Bulut, Zübeyde Bayram, Selahattin Akyol, Aykun Hakgör, Şeyhmus Külahçıoğlu, Ali Karagöz, Nihal Özdemir, Cihangir Kaymaz","doi":"10.14744/AnatolJCardiol.2025.5524","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5524","url":null,"abstract":"<p><strong>Background: </strong>Intermediate-high-risk (IHR) pulmonary embolism (PE) is defined by right ventricular (RV) dysfunction and elevated cardiac troponin in the absence of hemodynamic instability. While full-dose thrombolysis may improve outcomes, it poses a high bleeding risk. This study assessed the safety and efficacy of a reduced-dose, slow-infusion thrombolytic regimen.</p><p><strong>Methods: </strong>This single-center retrospective study included 124 patients with acute IHR PE who met at least one of the following criteria: systolic blood pressure ≤110 mm Hg, heart rate >100 bpm, SpO2 <90% on room air, respiratory rate >20/min, or lactate >2 mmol/L. Patients with contraindications to thrombolysis or symptom onset >14 days were excluded. Patients received 25 mg intravenous alteplase (t-PA) infused over 4-6 hours, along with standard anticoagulation according to the institutional protocol. Following the initial dose, a repeat infusion of 25 mg over 4-6 hours was administered if tachycardia, hypoxia, or signs of organ hypoperfusion persisted on re-evaluation.</p><p><strong>Results: </strong>Syncope was the presenting symptom in 27.4%, and 49.2% had deep vein thrombosis. Median t-PA dose was 50 mg and median infusion duration was 6 hours. Significant improvements were observed in RV and RA size/function, thrombus burden, and clinical parameters (all P < .001). Qanadli score and RV/LV ratio decreased by 55% and 29%, respectively. Major and minor bleeding occurred in 4.8% and 3.2%. In-hospital mortality was 4.8%; 12-month survival was 89.5%. Chronic thromboembolic pulmonary hypertension developed in 3.2%.</p><p><strong>Conclusion: </strong>Low-dose, slow-infusion t-PA therapy appears effective and well-tolerated, offering hemodynamic and clinical benefit with fewer bleeding complications in patients with IHR PE.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145079532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Self-Expanding Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis Undergoing Prosthetic Mitral Valve Replacement: A Single-Center Experience. 评论:自体扩张经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者的人工二尖瓣置换术:单中心经验。
IF 1.5 4区 医学
Anatolian Journal of Cardiology Pub Date : 2025-09-18 DOI: 10.14744/AnatolJCardiol.2025.5665
Muhammet Geneş, İdris Yakut
{"title":"Comment on: Self-Expanding Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis Undergoing Prosthetic Mitral Valve Replacement: A Single-Center Experience.","authors":"Muhammet Geneş, İdris Yakut","doi":"10.14744/AnatolJCardiol.2025.5665","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2025.5665","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145090910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信